文献速递神经核医学

注射后癫痫发作持续时间短与发作期脑灌注SPECT定侧致痫区能力降低相关

Short post-injection seizure duration is associated with reduced power of ictal brain perfusion SPECT to lateralize the seizure onset zone.
PubMed 文献 · EJNMMI Res · 2024-04-17

该研究回顾性纳入176例药物难治性癫痫患者的发作期脑灌注SPECT(99mTc-HMPAO 140例、-ECD 36例),由3名独立阅片者评估致痫区定侧与定位,发现注射后发作持续时间短(尤其≤10秒)与定侧比例降低相关(74.3% vs 86.3%,p=0.047),而注射潜伏期对定侧比例无显著影响(p=0.390)。

要点

  • 注射后发作持续时间短与发作期SPECT定侧比例降低相关(74.3% vs 86.3%,p=0.047)。
  • 该效应主要由注射后发作持续时间≤10秒的病例驱动(定侧比例53.8%)。
  • 注射潜伏期对定侧比例无显著影响(p=0.390),对定位比例也无显著影响(p≥0.603)。

核心结论

  • 注射后癫痫发作持续时间短与发作期脑灌注SPECT定侧病例比例较低相关。

研究设计与样本

  • 回顾性纳入176例药物难治性癫痫术前评估的发作期脑灌注SPECT,其中99mTc-HMPAO 140例、-ECD 36例。
  • 由3名独立阅片者结合个体MRI和统计高灌注图评估致痫区定侧与定位,阅片者间一致性用Fleiss κ表征。
  • 以中位数二分注射潜伏期和注射后发作持续时间作为组间因素,用ANOVA检验其对定侧/定位SPECT比例的影响。

主要发现

  • 注射潜伏期和注射后发作持续时间的中位数[四分位距](全距)分别为30[24, 40](3-120)秒和50[27, 70](-20-660)秒。
  • 致痫区定侧的Fleiss κ在早期(<30秒)注射联合长(>50秒)注射后发作持续时间时最大(κ=0.894,其他组合κ=0.659-0.734)。
  • 141例(80.1%)定侧SPECT中,致痫区定位的Fleiss κ在早期注射联合短注射后发作持续时间时最大(κ=0.575,其他组合κ=0.329-0.368)。
  • 注射后发作持续时间短者定侧SPECT比例低于长者(估计边际均值74.3% vs 86.3%,p=0.047),该效应主要由注射后发作持续时间≤10秒的病例驱动(定侧比例53.8%)。
  • 注射潜伏期在所考虑范围内对定侧SPECT比例无显著影响(p=0.390),定侧病例中定位SPECT比例不依赖注射潜伏期或注射后发作持续时间(p≥0.603)。

关键数值与推荐

  • 定侧SPECT定义为所有阅片者一致同意致痫区位于右或左半球。
  • 定位SPECT定义为定侧SPECT且所有阅片者一致同意同一半球内的同一脑叶。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to assess the impact of the post-injection electrical seizure duration on the identification of the seizure onset zone (SOZ) in ictal brain perfusion SPECT in presurgical evaluation of drug-resistant epilepsy. METHODS: 176 ictal SPECT performed with 99mTc-HMPAO (n = 140) or -ECD (n = 36) were included retrospectively. Visual interpretation of the SPECT images (together with individual MRI and statistical hyperperfusion maps) with respect to lateralization (right, left, none) and localization (temporal, frontal, parietal, occipital) of the SOZ was performed by 3 independent readers. Between-readers agreement was characterized by Fleiss' κ. An ictal SPECT was considered "lateralizing" if all readers agreed on right or left hemisphere. It was considered "localizing" if it was lateralizing and all readers agreed on the same lobe within the same hemisphere. The impact of injection latency and post-injection seizure duration on the proportion of lateralizing/localizing SPECT was tested by ANOVA with dichotomized (by the median) injection latency and post-injection seizure duration as between-subjects factors. RESULTS: Median [interquartile range] (full range) of injection latency and post-injection seizure duration were 30 [24, 40] (3-120) s and 50 [27, 70] (-20-660) s, respectively. Fleiss' κ for lateralization of the SOZ was largest for the combination of early (< 30 s) injection and long (> 50 s) post-injection seizure duration (κ = 0.894, all other combinations κ = 0.659-0.734). Regarding Fleiss' κ for localization of the SOZ in the 141 (80.1%) lateralizing SPECT, it was largest for early injection and short post-injection seizure duration (κ = 0.575, all other combinations κ = 0.329-0.368). The proportion of lateralizing SPECT was lower with short compared to long post-injection seizure duration (estimated marginal means 74.3% versus 86.3%, p = 0.047). The effect was mainly driven by cases with very short post-injection seizure duration ≤ 10 s (53.8% lateralizing). Injection latency in the considered range had no significant impact on the proportion of lateralizing SPECT (p = 0.390). The proportion of localizing SPECT among the lateralizing cases did not depend on injection latency or post-injection seizure duration (p ≥ 0.603). CONCLUSIONS: Short post-injection seizure duration is associated with a lower proportion of lateralizing cases in ictal brain perfusion SPECT.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Karimzadeh A, Baradaran-Salimi K, Voges B, et al. Short post-injection seizure duration is associated with reduced power of ictal brain perfusion SPECT to lateralize the seizure onset zone. EJNMMI Res. 2024. PMID: 38630381. doi:10.1186/s13550-024-01095-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。